DUNDEE, Scotland – Dundee University is renewing its pharma collaboration in protein phosphorylation and the kinase enzymes that control the central aspect of cellular function for the fourth time, in a £15 million (US$23.5 million) plus fees-for-service deal, which will extend the long-running program until 2016.